New Retina Radio by Eyetube

188 Episodes

1. ARVO Meeting Coverage Day 3: CANDELA and ARCHWAY Data

   Published: 6/9/2022
2. ARVO Meeting Coverage Day 2: Pipeline Therapies in GA

   Published: 6/2/2022
3. ARVO Meeting Coverage Day 1: LIGHTSITE III and DERBY/OAKS at 18 Months

   Published: 5/26/2022
4. New Treatment Options and Considerations for AMD

   Published: 5/19/2022
5. New Retina Radio Journal Club: Trends in Retina Reimbursement

   Published: 5/12/2022
6. New Retina Radio Journal Club: Diversity in Clinical Trials

   Published: 4/21/2022
7. New Retina Radio Journal Club: PPV vs PnR for RRD

   Published: 3/31/2022
8. Art of Drug Choice: Treating New Wet AMD Patients

   Published: 3/24/2022
9. Art of Drug Choice: Who Is Best Suited for Extended-duration Therapy?

   Published: 3/17/2022
10. Art of Drug Choice: The Latest Advances in Wet AMD Therapy

    Published: 3/3/2022
11. Anti-VEGF, A Biography: Part 3

    Published: 2/24/2022
12. Anti-VEGF, A Biography: Part 2

    Published: 2/17/2022
13. Exploring the clinical development program for an innovative, continuous delivery treatment for nAMD

    Published: 2/11/2022
14. Tackling PVR in the OR

    Published: 2/3/2022
15. Anti-VEGF, A Biography: Part 1

    Published: 1/27/2022
16. Perspectives on an innovative drug delivery system for nAMD: From training to initial experiences

    Published: 1/18/2022
17. Matching Patients to Therapy in Wet AMD: Lifestyle Factors That Guide Treatment

    Published: 1/4/2022
18. Matching Patients to Therapy in Wet AMD: Deciding Who Is Best Suited for Long-Duration Treatments

    Published: 12/22/2021
19. AAO 2021: Updates in Uveitis and Trauma

    Published: 12/17/2021
20. Matching Patients to Therapy in Wet AMD: How New Technology May Alleviate Treatment Burden

    Published: 12/14/2021